UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
(Mark One)
x
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2015
OR
¨
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to .
Commission File Number: 0-21810
GENTHERM INCORPORATED
(Exact name of registrant as specified in its charter)
Michigan
95-4318554
(State or other jurisdiction of
incorporation or organization)
(I.R.S. Employer
Identification No.)
21680 Haggerty Road, Ste. 101, Northville, MI
48167
(Address of principal executive offices)
(Zip Code)
Registrant’s telephone number, including area code: (248) 504-0500
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See the definitions of “large accelerated filer”, “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated filer
Accelerated filer
Non-accelerated filer
Smaller reporting company
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No x
At May 1, 2015, there were 35,904,826 issued and outstanding shares of Common Stock of the registrant.
TABLE OF CONTENTS
Cover
Table of Contents
Part I. Financial Information
3
Item 1.
Financial Statements (Unaudited)
Consolidated Condensed Balance Sheets
Consolidated Condensed Statements of Income
4
Consolidated Condensed Statements of Comprehensive Income
5
Consolidated Condensed Statements of Cash Flows
6
Consolidated Condensed Statement of Changes in Shareholders’ Equity
7
Notes to Unaudited Consolidated Condensed Financial Statements
8
Item 2.
Management’s Discussion and Analysis of Financial Condition and Results of Operations
14
Item 3.
Quantitative and Qualitative Disclosures About Market Risk
17
Item 4.
Controls and Procedures
20
Part II. Other Information
21
Legal Proceedings
Item 1A.
Risk Factors
Item 6.
Exhibits
Signatures
22
2
PART I. FINANCIAL INFORMATION
ITEM 1.
FINANCIAL STATEMENTS
CONSOLIDATED CONDENSED BALANCE SHEETS
(In thousands, except share data)
(Unaudited)
March 31,2015
December 31,2014
(unaudited)
ASSETS
Current Assets:
Cash and cash equivalents
$
79,581
85,700
Accounts receivable, less allowance of $2,858 and $2,847, respectively
147,545
136,183
Inventory:
Raw materials
51,404
48,678
Work in process
4,508
4,009
Finished goods
24,233
24,956
Inventory, net
80,145
77,643
Derivative financial instruments
2,362
145
Deferred income tax assets
5,532
6,247
Prepaid expenses and other assets
31,510
29,107
Total current assets
346,675
335,025
Property and equipment, net
92,444
91,727
Goodwill
27,673
30,398
Other intangible assets
58,171
68,129
Deferred financing costs
377
406
22,007
18,843
4,821
1,345
Other non-current assets
11,126
12,019
Total assets
563,294
557,892
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current Liabilities:
Accounts payable
84,544
71,434
Accrued liabilities
55,496
68,387
Current maturities of long-term debt
4,657
5,306
4,817
2,466
Total current liabilities
149,514
147,593
Pension benefit obligation
9,515
10,321
Other liabilities
5,460
2,788
Long-term debt, less current maturities
81,126
85,469
9,017
6,698
Deferred income tax liabilities
11,026
10,804
Total liabilities
265,658
263,673
Shareholders’ equity:
Common Stock:
No par value; 55,000,000 shares authorized, 35,890,326 and 35,696,334 issued and outstanding at March 31, 2015 and December 31, 2014, respectively
246,133
243,255
Paid-in capital
(8,185
)
(8,224
Accumulated other comprehensive loss
(45,063
(25,743
Accumulated earnings
104,751
84,931
Total shareholders’ equity
297,636
294,219
Total liabilities and shareholders’ equity
See accompanying notes to the consolidated condensed financial statements.
CONSOLIDATED CONDENSED STATEMENTS OF INCOME
(In thousands, except per share data)
Three Months EndedMarch 31,
2015
2014
Product revenues
206,909
193,938
Cost of sales
140,339
136,913
Gross margin
66,570
57,025
Operating expenses:
Net research and development expenses
14,548
13,045
Acquisition transaction expenses
—
1,075
Selling, general and administrative
24,945
17,867
Total operating expenses
39,493
31,987
Operating income
27,077
25,038
Interest expense
(564
(931
Revaluation of derivatives loss
(964
(247
Foreign currency gain (loss)
435
(1,523
Gain from equity investment
785
Other income (expense)
195
(241
Earnings before income tax
26,179
22,881
Income tax expense
6,359
6,302
Net income
19,820
16,579
Basic earnings per share
0.55
0.47
Diluted earnings per share
Weighted average number of shares – basic
35,769
35,064
Weighted average number of shares – diluted
36,245
35,592
CONSOLIDATED CONDENSED STATEMENTS OF COMPREHENSIVE INCOME
(In thousands)
Three Months Ended
March 31,
Other comprehensive income (loss), gross of tax:
Foreign currency translation adjustments loss
(19,605
(2,625
Unrealized gain (loss) on foreign currency derivative securities
(347
61
Unrealized gain on commodity derivative securities
76
Unrealized gain on interest rate derivative securities
39
Other comprehensive loss, gross of tax
(19,876
(2,525
Other comprehensive income (loss), related tax effect:
Foreign currency translation adjustments
467
574
Unrealized gain on foreign currency derivative securities
89
Other comprehensive income, related tax effect
556
Other comprehensive loss, net of tax
(19,320
(1,951
Comprehensive income
500
14,628
CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS
Three Months Ended March 31,
Operating Activities:
Adjustments to reconcile net income to cash provided by (used in) operating activities:
Depreciation and amortization
7,459
7,473
Deferred income tax benefit
(2,483
(1,804
Stock compensation
1,358
870
Defined benefit plan (income) expense
(9
1
Provision of doubtful accounts
125
(4
Gain on revaluation of financial derivatives
(324
(557
(785
Excess tax benefit from equity awards
(2,173
(Gain) loss on sale of property and equipment
(8
24
Changes in operating assets and liabilities:
Accounts receivable
(15,994
(21,153
Inventory
(5,762
457
(3,905
(5,786
15,522
2,798
(6,970
904
Net cash provided by (used in) operating activities
8,829
(3,156
Investing Activities:
Investment in subsidiary, net of cash acquired
(47
(628
Proceeds from the sale of property and equipment
181
44
Purchases of property and equipment
(10,403
(6,769
Net cash used in investing activities
(10,269
(7,353
Financing Activities:
Borrowing of debt
13,455
Repayments of debt
(1,669
(6,965
2,173
Cash paid for the cancellation of restricted stock
(467
Proceeds from the exercise of Common Stock options
2,026
1,634
Net cash provided by (used in) financing activities
(110
10,297
Foreign currency effect
(4,569
2,978
Net increase (decrease) in cash and cash equivalents
(6,119
2,766
Cash and cash equivalents at beginning of period
54,885
Cash and cash equivalents at end of period
57,651
Supplemental disclosure of cash flow information:
Cash paid for taxes
14,768
4,689
Cash paid for interest
515
725
Supplemental disclosure of non-cash transactions:
Common Stock issued to Board of Directors and employees
673
495
CONSOLIDATED CONDENSED STATEMENT OF CHANGES IN SHAREHOLDERS’ EQUITY
Accumulated
Other
Common Stock
Paid-in
Comprehensive
Shares
Amount
Capital
Earnings
Loss
Total
Balance at December 31, 2014
35,697
Exercise of Common Stock options for cash
123
2,672
(646
Cancelation of restricted stock
(11
Stock option compensation
685
81
Currency translation, net
(19,138
Commodity hedge, net
Foreign currency hedge, net
(258
Balance at March 31, 2015
35,890
NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS
(In thousands, except share and per share data)
Note 1 – The Company and Subsequent Events
Gentherm Incorporated is a global technology and industry leader in the design, development, and manufacturing of innovative thermal management technologies. Unless the context otherwise requires, the terms “Company”, “we”, “us” and “our” used herein refer to Gentherm Incorporated and its consolidated subsidiaries. Our products can be found on the vehicles of nearly all major automotive manufacturers, spanning all major automotive markets. We operate in locations aligned with our major customers’ product strategies in order to provide locally enhanced design, integration and production capabilities and to identify future thermal technology product opportunities in both automotive and other markets. We concentrate our research on the development of new technologies that will improve overall product effectiveness and customer satisfaction. We also focus on developing new design applications from our existing technologies to create products and market opportunities for thermal comfort solutions.
Subsequent Events
We have evaluated subsequent events through the date that our consolidated condensed financial statements are issued. No events have occurred that would require adjustment to or disclosure in the consolidated condensed financial statements.
Note 2 – Basis of Presentation and New Accounting Pronouncements
The accompanying unaudited consolidated condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and pursuant to the rules and regulations of the Securities and Exchange Commission. Certain information and note disclosures normally included in the audited annual consolidated financial statements prepared in accordance with generally accepted accounting principles in the United States of America have been condensed or omitted pursuant to those rules and regulations. In the opinion of management, all adjustments, consisting of normal recurring items, considered necessary for a fair presentation of our results of operations, financial position and cash flows have been included. The balance sheet as of December 31, 2014 was derived from audited annual consolidated financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States of America. Operating results for the three months ended March 31, 2015 is not necessarily indicative of the results that may be expected for the year ending December 31, 2015. These consolidated condensed financial statements should be read in conjunction with the financial statements and the notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2014.
Revenue from Contracts with Customers
In May, 2014, the Financial Accounting Standards Board (FASB) issued ASU 2014-09, “Revenue from Contracts with Customers.” ASU 2014-09 was developed to enable financial statement users to better understand the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers. The update’s core principal is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. Companies are to use a five-step contract review model to ensure revenue gets recognized, measured and disclosed in accordance with this principal.
ASU 2014-09 is effective for fiscal years and interim periods beginning after December 15, 2016. The amendments in this update should be applied retrospectively either to each prior reporting period presented or to disclose the cumulative effect recognized at the date of initial application. Gentherm has developed a plan to complete the five-step contract review process for all existing contracts with customers. We are still in the process of determining the impact the implementation of ASU 2014-09 will have on the Company’s financial statements.
Note 3 – Earnings per Share
Basic earnings per share are computed by dividing net income by the weighted average number of shares of stock outstanding during the period. The Company’s diluted earnings per share give effect to all potential common shares outstanding during a period that do not have an anti-dilutive impact to the calculation. In computing the diluted earnings per share, the treasury stock method is used in determining the number of shares assumed to be issued from the exercise of Common Stock equivalents.
Note 3 – Earning Per Share – Continued
The following summarizes the common shares included in the basic and diluted shares, as disclosed on the face of the consolidated condensed statements of income:
Three MonthsEnded March 31,
Weighted average number of shares for calculation of basic EPS
35,769,190
35,063,671
Stock options under the 2006, 2011 and 2013 equity plans
475,505
528,356
Weighted average number of shares for calculation of diluted EPS
36,244,695
35,592,027
The accompanying table represents Common Stock issuable upon the exercise of certain stock options that have been excluded from the diluted shares calculation because the effect of their inclusion would be anti-dilutive.
Stock options outstanding under the 2006, 2011 and 2013 Equity Incentive Plans
Note 4 – Segment Reporting
Segment information is used by management for making operating decisions for the Company. Management evaluates the performance of the Company’s segments based primarily on operating income or loss.
The Company’s reportable segments are as follows:
●
Automotive – this segment represents the design, development, manufacturing and sales of automotive seat comfort systems, specialized automotive cable systems and certain automotive and non-automotive thermal convenience products.
Industrial – the combined operating results of Gentherm Global Power Technologies and Gentherm’s advanced research and development division. Advanced research and development includes efforts focused on improving the efficiency of thermoelectric technologies and advanced heating wire technology as well as other applications. The segment includes government sponsored research projects, including those sponsored by the U.S. Department of Energy, the Germany Ministry of Economics and Technology and the European Union.
Reconciling Items – include corporate selling, general and administrative costs and acquisition transaction costs.
The table below presents segment information about the reported product revenues, depreciation and amortization and operating income (loss) of the Company for three months ended March 31, 2015 and 2014. Certain amounts for 2014 have been reclassified to conform with the current year presentation. With the exception of goodwill, asset information by segment is not reported since the Company does not manage assets at a segment level. As of March 31, 2015, goodwill assigned to our Automotive and Industrial segments were $21,368 and $6,305, respectively. Goodwill as of March 31, 2014 pertained entirely to our Automotive segment.
9
Note 4 – Segment Reporting – Continued
Automotive
Industrial
ReconcilingItems
ConsolidatedTotal
2015:
199,443
7,466
6,316
489
654
Operating income (loss)
40,682
(1,106
(12,499
2014:
6,482
107
884
35,174
(1,550
(8,586
Total product revenues information by geographic area is as follows:
United States
95,304
46
%
85,067
South Korea
22,863
11
21,915
Germany
18,840
22,476
12
China
17,970
15,944
Japan
11,185
10,465
United Kingdom
6,988
6,600
Czech Republic
6,159
6,086
Canada
5,485
3,162
Mexico
5,433
4,703
16,682
17,520
Total Non U.S.
111,605
54
108,871
56
100
Note 5 – Debt
Credit Agreement
The Company, together with certain direct and indirect subsidiaries have an outstanding Credit Agreement (the “Credit Agreement”) with a syndicate of banks led by Bank of America.
The Credit Agreement provides for a $50,000 secured term loan facility for Gentherm (the “US Term Loan”), and a €20,000 secured term loan facility for Gentherm GmbH (the “Europe Term Loan”), and a $100,000 secured revolving credit facility (the “US Revolving Note”) with specific borrowing limits for foreign subsidiaries party to such agreement. The Credit Agreement allows the Company to increase the revolving credit facility or incur additional secured term loans in an aggregate amount of $50,000, subject to specific conditions.
All obligations under the Credit Agreement (including all the obligations of any US or non-US loan party) are unconditionally guaranteed by Gentherm and specified US subsidiaries. Additionally, such parties entered into a pledge and security agreement, granting a security interest in substantially all of their personal property to secure their respective obligations under the Credit Agreement, including the stock and membership interests of specified subsidiaries (limited to 66% of the stock in the case of certain non-US subsidiaries). Further, specified foreign subsidiaries guarantee all obligations of the non-US loan parties under the Credit Agreement.
The Company must maintain certain financial ratios consisting of a minimum Consolidated Fixed Charge Coverage Ratio and a maximum Consolidated Leverage Ratio as defined by the Credit Agreement. The Credit Agreement places specific restrictions on the amount of dividend payments to shareholders.
10
Note 5 – Debt – Continued
Under the Credit Agreement, U.S. Dollar denominated loans bear interest at either a base rate (“Base Rate Loans”) or Eurocurrency rate (“Eurocurrency Rate Loans”), plus a margin (“Applicable Rate”). Base Rate Loans are equal to the highest of the Federal Funds Rate (0.06% at March 31, 2015) plus 0.50%, Bank of America’s prime rate (3.25% as of March 31, 2015), or a one month Eurocurrency rate plus 1.00%. Eurocurrency Rate Loans denominated in US Dollars or European Euros (“Euros”) are equal to the London Interbank Offered Rate and the Canadian Dealer Offered Rate for Canadian Dollar denominations. All loans denominated in a currency other than the US Dollar, including the Europe Term Loan, must be Eurocurrency Rate Loans. Interest is payable at least quarterly.
The Applicable Rate varies based on the Consolidated Leverage Ratio of the Company, as defined by the Credit Agreement. As long as the Company is not in default of the terms and conditions of the Credit Agreement, the lowest and highest possible Applicable Rate is 1.50% and 2.00%, respectively, for Eurocurrency Rate Loans and 0.50% and 1.00%, respectively, for Base Rate Loans. Our leverage ratio as of March 31, 2015 qualified us for the lowest Applicable Rate available.
DEG Loan
The Company has a fixed interest rate loan with the German Investment Corporation, a subsidiary of KfW banking group (“DEG”), a German government-owned development bank (“DEG Loan”). The DEG Loan is subject to semi-annual principal payments beginning March, 2015 and ending September, 2019. Under the terms of the DEG Loan, the Company must maintain a minimum Debt-to-Equity Ratio, Current Ratio and Debt Service Coverage Ratio based on the financial statements of Gentherm’s wholly owned subsidiary, Gentherm Automotive Systems (China) Limited, as defined by the DEG Loan agreement.
The following table summarizes the Company’s debt at March 31, 2015 and at December 31, 2014.
March 31, 2015
InterestRate
PrincipalBalance
Credit Agreement:
US Term Loan
1.78
48,750
49,375
Europe Term Loan
1.51
20,943
23,963
US Revolving Note
1.68
12,000
4.25
3,866
4,805
Capital leases
4.20
224
632
Total debt
85,783
90,775
Current portion
(4,657
(5,306
As of March 31, 2015, we were in compliance with all terms as outlined in the Credit Agreement, the DEG Loan and the capital lease agreement.
Note 6 – Derivative Financial Instruments
We are exposed to market risk from changes in foreign currency exchange rates, short-term interest rates and price fluctuations of certain material commodities such as copper. Market risks for changes in interest rates relate primarily to our debt obligations under our Credit Agreement and obligations from currency related interest rate swaps. Foreign currency exchange risks are attributable to sales to foreign customers and purchases from foreign suppliers not denominated in the location’s functional currency, foreign plant operations, intercompany indebtedness, and intercompany investments and include exposures to the Euro, Mexican Peso, Canadian Dollar, Hungarian Forint, Ukrainian Hryvnia, Japanese Yen, Chinese Renminbi, Vietnamese Dong and Korean Won.
Note 6 – Derivative Financial Instruments – Continued
The Company regularly enters into derivative contracts with the objective of managing its financial and operational exposure arising from these risks by offsetting gains and losses on the underlying exposures with gains and losses on the financial instruments used to hedge them. The maximum length of time over which we hedge our exposure to foreign currency exchange risks is one year. We do not enter into derivative financial instruments for speculative or trading purposes. Our hedging relationships are formally documented at the inception of the hedge, and hedges must be highly effective in offsetting changes to future cash flows on hedged transactions both at the inception of a hedge and on an ongoing basis to be designated for hedge accounting treatment. We record the ineffective portion of foreign currency hedging instruments, if any, to foreign currency gain (loss) in the consolidated condensed statements of income. Though we continuously monitor the hedging program, derivative positions and hedging strategies, foreign currency forward exchange agreements have not always been designated as hedging instruments for accounting purposes.
The Company uses a market approach to value derivative instruments, analyzing observable benchmark rates at commonly quoted intervals for the instrument’s full term.
In March, 2008, Gentherm GmbH, entered into a 10 year currency related interest rate swap (“CRS”) having a notional value of €10,000, or $10,740 as of March 31, 2015, in order to offset the interest rate risk associated with a debt financing which was repaid prior to our acquisition of Gentherm GmbH in 2011. The counterparty to the CRS was HypoVereinsbank AG (now UniCredit Bank AG, “UniCredit”), its main bank at the time. Under this agreement, Gentherm GmbH receives interest equal to the six month Euro Interbank Offered Rate (“EURIBOR”), 0.09% at March 31, 2015, plus 1.40% and pays interest equal to the six month EURIBOR when the exchange rate between the European Euro (“EUR”) and the Swiss Franc (“CHF”) equals or exceeds 1.46 EUR to the CHF. When the exchange rate is less than 1.46 (it was 1.05 at March 31, 2015), Gentherm GmbH pays interest equal to the six month EURIBOR plus a premium. The premium is calculated as [(1.46 – current EUR/CHF rate)/current EUR/CHF rate] x 100.
In 2011, Gentherm GmbH brought forth a lawsuit against UniCredit, because of the recommendation to enter into the CRS. On March 25, 2013, the District Court in Munich, Germany ruled in favor of Gentherm GmbH, asserting that UniCredit had a conflict of interest as financial advisor and counterparty to the CRS and violated its duty to disclose the initial negative market value of the CRS. The Munich District Court ruled that UniCredit must (1) pay €144 to Gentherm GmbH and (2) bear the costs of all future obligations under the CRS, which were €12,413 or $13,332 as of March 31, 2015, plus additional accrued liabilities for past due payments under the CRS of approximately €8,978, or $9,642 as of March 31, 2015. UniCredit has appealed the decision. The appeal is pending. As a result, the Company cannot be certain that any portion of the award by the Munich District Court will be upheld. Gentherm GmbH has entered into an offsetting derivative contract designed to limit the market risk of payments due under the CRS through the end of the CRS agreement, in 2018.
Information related to the recurring fair value measurement of derivative instruments in our consolidated condensed balance sheet as of March 31, 2015 is as follows:
Asset Derivatives
Liability Derivatives
Net Asset/ (Liabilities)
Hedge Designation
Fair ValueHierarchy
Balance SheetLocation
FairValue
CRS
Not a hedge
Level 2
Current liabilities
(4,315
Non-current liabilities
(9,017
Total CRS
(13,332
Foreign currency derivatives
Cash flow hedge
Current assets
158
(502
(344
2,128
Non-currentassets
Total foreign currency derivatives
7,107
6,605
Commodity derivatives
Information relating to the effect of derivative instruments on our consolidated condensed statements of income is as follows:
Location
Three MonthsEndedMarch 31,2015
Three MonthsEndedMarch 31,2014
Revaluation of derivatives
6,197
262
(128
(53
(48
Other comprehensive income
207
(453
5,950
(231
(7,161
(509
Interest rate derivatives
We did not incur any hedge ineffectiveness during the three months ended March 31, 2015 and 2014.
Note 7 – Fair Value Measurement
The Company bases fair value on the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. We have adopted a fair value hierarchy that prioritizes observable and unobservable inputs used to measure fair value into three broad levels, which are described below:
Level 1: Quoted prices (unadjusted) in active markets that are accessible at the measurement date for assets or liabilities. The fair value hierarchy gives the highest priority to Level 1 inputs.
Level 2: Observable prices that are based on inputs not quoted on active markets, but corroborated by market data.
Level 3: Unobservable inputs that are used when little or no market data is available. The fair value hierarchy gives the lowest priority to Level 3 inputs.
In determining fair value, the Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible and also considers counterparty credit risk in its assessment of fair value.
Except for derivative instruments (see Note 6), pension liabilities and pension plan assets, the Company has no financial assets and liabilities that are carried at fair value at March 31, 2015 and December 31, 2014. The carrying amounts of financial instruments comprising cash and cash equivalents, accounts receivable, accounts payable and accrued liabilities approximate their fair values due to the relatively short maturity of such instruments. The fair values of the Company’s debt instruments are based on the amount of future cash flows associated with each instrument discounted using the Company’s borrowing rate. As of March 31, 2015 and December 31, 2014, the carrying value of debt instruments was not materially different than its fair value because the interest rates on variable rate debt approximated rates currently available to the Company (see Note 5).
Certain Company assets are required to be recorded at fair value on a non-recurring basis when events and circumstances indicate that the carrying value may not be recoverable. As of March 31, 2015 and 2014, the Company did not realize any changes to the fair value of these assets due to the non-occurrence of events or circumstances that could negatively impact their recoverability.
13
ITEM 2.
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Forward-Looking Statements
This Report contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Reference is made in particular to the description of our plans and objectives for future operations, assumptions underlying such plans and objectives and other forward-looking statements included in this “Item 2 Management’s Discussion and Analysis of Financial Condition and Results of Operations” and in other places in this Report. Such statements may be identified by the use of forward-looking terminology such as “may”, “will”, “expect”, “believe”, “estimate”, “anticipate”, “intend”, “continue” or similar terms, variations of such terms or the negative of such terms. The forward-looking statements included in this Report are made as of the date hereof and are based on management’s current expectations and beliefs. Such statements are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements, including risks and uncertainties set forth in this Report, and under “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2014 and in subsequent reports filed with or furnished to the Securities and Exchange Commission. Except as required by law, we expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in our expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based.
The following discussion and analysis should be read in conjunction with, and is qualified in its entirety by, our financial statements and related notes thereto included elsewhere in this Report and in our Annual Report on Form 10-K for the year ended December 31, 2014.
Overview
Gentherm is a global technology and industry leader in the design, development, and manufacturing of innovative thermal management technologies and automotive cable systems. Our products can be found on the vehicles of nearly all major automotive manufacturers, spanning all major automotive markets. We operate in locations aligned with our major customers’ product strategies in order to provide locally enhanced design, integration and production capabilities and identify future climatic comfort product opportunities in both automotive and other markets. We concentrate our research on the development of new technologies that will improve overall product effectiveness and customer satisfaction. We also focus on developing new design applications from our existing technologies to create new products and market opportunities for thermal comfort solutions.
Our products are primarily sold to automobile and light truck original equipment manufacturers or their tier one suppliers. Inherent in this market are costs and commitments that are incurred well in advance of the receipt of orders (and resulting revenues) from customers. This is due in part to automotive manufacturers requiring the design, coordination and testing of proposed new components and sub-systems. Revenues from these expenditures are typically not realized for two to three years due to this development cycle. These customers in turn sell our product, as a component of an entire seat or seating system, to automotive original equipment manufacturers.
First Quarter 2015 Compared with First Quarter 2014
Product Revenues. Our product revenues for the three months ended March 31, 2015 (“First Quarter 2015”) were $206,909,000 compared with product revenues of $193,938,000 for the three months ended March 31, 2014 (“First Quarter 2014”), an increase of $12,971,000, or 7%. A portion of our product revenues come from sales to customers in Europe much of which are denominated in European Euros (“Euro”). During the last two quarters, the relative market value of the Euro has declined significantly against the US Dollar, our reporting currency. During the First Quarter 2015 the average exchange rate between these currencies was 1.13 US Dollars to the Euro whereas during the First Quarter 2014 the average exchange rate was 1.37. Consequently, our Euro dominated revenues which have increased by 7%, in Euros, have resulted in a decrease in our US Dollar reported product revenues. Had the 2015 average exchange rate been the same as the 2014 average exchange rate for the Euro, our product revenues would have been $10,209,000 higher that reported for First Quarter 2015. Adjusting for this unfavorable Euro currency translation impact, our First Quarter 2015 product revenues would have been $217,118,000 or 12% higher than the First Quarter 2014, reflecting higher unit volumes in substantially all of our markets and products. Higher revenue volumes were primarily driven by continued strong shipments of climate controlled seats (“CCS”) and revenue of $7,466,000 from Gentherm Global Power Technologies (“GPT”), which was acquired on April 1, 2014. CCS revenue increased by $12,118,000, or 15%, to $94,428,000, during First Quarter 2015. This increase resulted from new program launches since the First Quarter 2014, strong production volumes and related sales of vehicles equipped with CCS systems, particularly vehicles in the luxury segment of the automotive market. One example of a new vehicle launch is the newly redesigned Ford Mustang, which now offers CCS for the first time. Our seat heater revenue decreased by $7,684,000, or 9%, to approximately $73,727,000. This decrease reflected the unfavorable impact of the declining Euro exchange rate. Our seat heater product sales in Europe are denominated in Euro, whereas our CCS sales in Europe are primarily denominated in US Dollars. Therefore, the unfavorable impact of the lower Euro translation rate is focused primarily on our seat heater product sales. Adjusted for the decline in the value of the Euro, our seat heater sales actually increased due to market penetration on certain vehicle
programs and stronger vehicle production volumes including those in Europe. We also have significant growth in our heated steering wheel product which showed an increase of $990,000, or 11%, to $9,767,000.
Cost of Sales. Cost of sales increased to $140,339,000 in First Quarter 2015 from $136,913,000 in First Quarter 2014. This increase of $3,426,000 or 2.5% was due to increased sales volume, including that of GPT, partially offset by higher gross margin percentages. A favorable change in product mix, greater coverage of fixed costs at the higher volume levels, and foreign currency impact on production expenses in the Mexican Peso (“MXN”) and Ukrainian Hryvnia (“UAH”) increased historical gross profit percentage during First Quarter 2015 to 32.2% compared with 29.4% during First Quarter 2014. The favorable product mix was primarily attributable to the greater sales growth in CCS products on which we have historically had better margin performance. Our manufacturing plants are located in the Ukraine, Mexico, Canada and China. As a result, our production labor costs are incurred in the local currency of each of those countries. During the First Quarter 2015, MXN and UAH decreased in value as compared to the USD by 11% and 56%, respectively, resulting in lower production costs totaling $3,720,000.
Net Research and Development Expenses. Net research and development expenses were $14,548,000 during First Quarter 2015 compared to $13,045,000 in First Quarter 2014, an increase of $1,503,000, or 11.5%. This increase was primarily driven by additional resources, including personnel, focused on application engineering for new production programs of existing products, development of new products and a program to develop the next generation of seat comfort products. New product development includes automotive heated and cooled storage devices, automotive interior thermal management devices, medical thermal management devices, battery thermal management devices and other potential products. Net research and development expenses also increased by $289,000 due to the acquisition of GPT.
We classify development and prototype costs and related reimbursements as research and development. This is consistent with accounting standards applied in the automotive industry. Depreciation costs for tooling are included in cost of sales.
Acquisition Transaction Expenses. During First Quarter 2014, we incurred $1,075,000 in fees and expenses associated with the acquisition of GPT. We did not incur any acquisition transaction expenses during the First Quarter 2015.
Selling, General and Administrative Expenses. Selling, general and administrative expenses increased to $24,945,000 in First Quarter 2015 from $17,867,000 in First Quarter 2014, an increase of $7,078,000, or 39.6%. The increase in selling, general and administrative expenses includes the expenses of GPT totaling $2,035,000. The remaining increase in expenses was due to increased management incentive compensation costs, higher general legal, audit and travel costs, as well as wages and benefits costs resulting from new employee hiring and merit increases. Our management incentive program includes various forms of equity compensation including stock options, restricted stock and stock appreciation rights (“SARs”). Stock options and restricted stock are accounted for using the equity method and are valued at the grant date fair value and amortized over the respective service period of the employee beneficiary. SARs are accounted for using the liability method since they are settled in cash which requires mark-to-market adjustments based on the current trading price of Gentherm Common Stock. Since Gentherm Common Stock appreciated significantly during the First Quarter 2015, we recorded SAR related compensation expense totaling $3,700,000 for the period. The SAR related compensation expense increased $2,700,000 from $1,000,000 during First Quarter 2014.
Income Tax Expense. We recorded an income tax expense of $6,359,000 during First Quarter 2015 representing an effective tax rate of 24.3% on earnings before income tax of $26,179,000. We recorded an income tax expense of $6,302,000 during First Quarter 2014 representing an effective tax rate of 27.5% on earnings before income tax of $22,881,000. The effective tax rates for First Quarter 2015 and First Quarter 2014 were lower than the US Federal rate of 34% primarily due to the impact of lower statutory rates for our subsidiaries operating in foreign jurisdictions.
Liquidity and Capital Resources
The Company has funded its financial needs primarily through cash flows from operating activities and equity and debt financings. Based on its current operating plan, management believes cash and cash equivalents at March 31, 2015, together with cash flows from operating activities, are sufficient to meet operating and capital expenditure needs, and to service debt, for the foreseeable future. However, if cash flows from operations decline, we may need to obtain alternative sources of capital and reduce or delay capital expenditures, acquisitions and investments, all of which could impede the implementation of our business strategy and materially and adversely affect our results of operations and financial condition. In addition, it is likely that we will need to complete one or more equity or debt financings if we consummate any significant acquisitions. There can be no assurance that such capital will be available at all or on reasonable terms, which could materially and adversely affect our future operations and business strategy.
15
The following table represents our cash and cash equivalents and short-term investments which are available for our business operations:
We manage our cash, cash equivalents and short-term investments in order to fund operating requirements and preserve liquidity to take advantage of future business opportunities. Cash and cash equivalents decreased by $6,119,000 in First Quarter 2015. Cash provided by operating activities during First Quarter 2015 was $8,829,000 and was attributable to net income of $19,820,000, plus non-cash adjustments. Non-cash adjustments included depreciation and amortization of $7,459,000, stock compensation of $1,358,000 and other items. Partially offsetting these positive cash flows from operating activities was a net increase in net operating assets and liabilities of $17,109,000, including working capital items, deferred income tax benefit of $2,483,000 and gains on the revaluation of derivatives of $324,000.
As of March 31, 2015, working capital was $197,161,000 as compared to $187,432,000 at December 31, 2014, an increase of $9,729,000, or 5.2%. This increase was primarily related to increases in accounts receivable, inventory, and prepaid expenses and other assets and decreases in accrued liabilities and in the current portion of long-term debt totaling $15,994,000, $5,762,000, $3,905,000, $6,970,000 and $649,000, respectively. These increases in working capital were partially offset by an increase in accounts payable of $15,522,000 and a decrease in deferred income tax assets of $715,000. Accounts receivable primarily increased as a result of increases in product revenues and timing differences between when sales in First Quarter 2015 were realized compared with sales realized in 2014. Working capital was also affected by changes in currency exchange rates. As a result, amounts presented are different than amounts calculable from the balance sheet.
Cash used in investing activities was $10,269,000 during First Quarter 2015, reflecting the acquisition of property and equipment totaling $10,403,000. Purchases of property and equipment for the period related to expansion of production capacity, replacement of existing equipment and construction of new production facilities in Vietnam and Macedonia. These new facilities will begin to expand our manufacturing capacities in Asia and Europe by the end of 2015. The total cost to construct these facilities is estimated at $15,000,000 to $20,000,000.
Cash used by financing activities was $110,000 during First Quarter 2015. Payment of principal on the US Term Loan, Europe Term Loan, DEG Loan and capital lease totaled $1,669,000. Cash paid for the tax related to the cancellation of restricted stock awards totaled $467,000. These cash flow uses were substantially offset by proceeds from the exercise of Common Stock options of $2,026,000. See Note 5 to the consolidated condensed financial statements included herein for information about borrowings under the Credit Agreement.
16
ITEM 3.
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
We are exposed to market risk from changes in foreign currency exchange rates, short-term interest rates and price fluctuations of certain material commodities such as copper. Market risks for changes in interest rates relate primarily to our debt obligations under our Credit Agreement and obligations from currency related interest rate swaps. We have in the past, and may in the future, make investments in bank certificates of deposits, debt instruments of the U. S. government, and in high-quality corporate issuers to mitigate the risks from short-term interest rate fluctuations. Foreign currency exchange risks are attributable to sales to foreign customers and purchases from foreign suppliers not denominated in the location’s functional currency, foreign plant operations, intercompany indebtedness, intercompany investments and include exposures to the European Euro, Mexican Peso, Canadian Dollar, Hungarian Forint, Ukrainian Hryvnia, Japanese Yen, Chinese Renminbi, Vietnamese Dong and Korean Won.
In March, 2008, Gentherm GmbH, entered into a 10 year currency related interest rate swap (“CRS”) having a notional value of €10,000,000, or $10,740,000 as of March 31, 2015, in order to offset the interest rate risk associated with a debt financing which was repaid prior to our acquisition of Gentherm GmbH. The counterparty of the CRS was HypoVereinsbank AG (now UniCredit Bank AG, “UniCredit”), its main bank at the time. Under this agreement, Gentherm GmbH receives interest equal to the six month Euro Interbank Offered Rate (“EURIBOR”), 0.09% at March 31, 2015, plus 1.40% and pays interest equal to the six month EURIBOR when the exchange rate between the European Euro (“EUR”) and the Swiss Franc (“CHF”) equals or exceeds 1.46 EUR to the CHF. When the exchange rate is less than 1.46 (it was 1.05 at March 31, 2015), Gentherm GmbH pays interest equal to the six month EURIBOR plus a premium. The premium is calculated as [(1.46 – current EUR/CHF rate)/current EUR/CHF rate] x 100.
In 2011, Gentherm GmbH brought a lawsuit against UniCredit, because of the recommendation to enter into the CRS. On March 25, 2013, the District Court in Munich, Germany ruled in favor of Gentherm GmbH, asserting that UniCredit had a conflict of interest as financial advisor and counterparty to the CRS and violated its duty to disclose the initial negative market value of the CRS. The Munich District Court ruled that UniCredit must (1) pay €144,000 to Gentherm GmbH and (2) bear the costs of all future obligations under the CRS, which were €12,413,000 or $13,332,000 as of March 31, 2015, plus additional accrued liabilities for past due payments under the CRS of approximately €8,978,000, or $9,642,000 as of March 31, 2015. UniCredit has appealed the decision. The appeal is pending. As a result, the Company cannot be certain that any portion of the award by the Munich District Court will be upheld. Gentherm GmbH has entered into an offsetting derivative contract designed to limit the market risk of payments due under the CRS through the end of the CRS agreement, in 2018.
Information related to the fair values of all derivative instruments in our consolidated condensed balance sheet as of March 31, 2015 is set forth in Note 6 to the consolidated condensed financial statements included herein.
Interest Rate Sensitivity
The table presents principal cash flows and related weighted average interest rates by expected maturity dates for each of the Company’s debt obligations. The information is presented in U.S. dollar equivalents, which is the Company’s reporting currency. The instruments actual cash flows are denominated in U.S. dollars ($USD) or European Euros (€EUR), as indicated in parentheses.
Expected Maturity Date
2016
2017
2018
2019
(In thousands except rate information)
Liabilities
Long Term Debt:
Fixed Rate (€EUR)
Average Interest Rate
430
859
Variable Rate ($USD)
1,875
2,813
3,750
4,062
48,250
60,750
1.76
Variable Rate (€EUR)
806
1,208
1,611
1,745
15,573
Exchange Rate Sensitivity
The table below provides information about the Company’s foreign currency forward exchange rate agreements that are sensitive to changes in foreign currency exchange rates. The table presents the notional amounts and weighted average exchange rates by expected (contractual) maturity dates for each type of foreign currency forward exchange agreement. These notional amounts generally are used to calculate the contractual payments to be exchanged under the contract.
Expected Maturity or Transaction Date
Anticipated Transactions And Related Derivatives
Thereafter
Euro functional currency
Forward Exchange Agreements:
(Receive HUF/Pay EUR€)
Total Contract Amount (€)
€
3,637
146
Average Contract Rate
313.48
(Receive CHF/Pay EUR€)
6,218
12,437
12,302
6,151
37,108
6,453
1.20
$US functional currency
(Receive MXN/Pay USD$)
Total Contract Amount ($)
16,580
(459
14.87
(Receive EUR€/Pay USD$)
913
1.07
(Receive CAD/Pay USD$)
1,808
1.27
18
Commodity Price Sensitivity
The table below provides information about the Company’s futures contracts that are sensitive to changes in commodity prices, specifically copper prices. For the futures contracts the table presents the notional amounts in metric tons (MT), the weighted average contract prices, and the total dollar contract amount by expected maturity dates. Contract amounts are used to calculate the contractual payments and quantity of copper to be exchanged under the futures contracts.
CarryingAmount
On Balance Sheet Commodity Position and Related Derivatives
76,000
ExpectedMaturity2015
Related Derivatives
Futures Contracts (Long):
Contract Volumes (metric tons)
590
Weighted Average Price (per metric ton)
5,895
Contract Amount ($)
3,478,050
19
ITEM 4.
CONTROLS AND PROCEDURES
(a) Evaluation of Disclosure Controls and Procedures
As of the end of the period covered by this quarterly report, we carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as of March 31, 2015, our disclosure controls and procedures were effective to ensure the information required to be disclosed by us in reports that we file or submit under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized, and reported within the time periods prescribed by the Securities and Exchange Commission, and that such information is accumulated and communicated to management, including the Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.
(b) Changes in Internal Control over Financial Reporting
There were no changes in our internal control over financial reporting that occurred during the quarter ended March 31, 2015 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
PART II OTHER INFORMATION
LEGAL PROCEEDINGS
We are subject to litigation from time to time in the ordinary course of our business, however there is no current material pending litigation to which we are a party and no material legal proceeding was terminated, settled or otherwise resolved during the first quarter of the fiscal year ended December 31, 2015. See Note 6 to the consolidated condensed financial statements for information regarding the dispute with UniCredit Bank AG and our currency related interest rate swaps.
ITEM 1A.
RISK FACTORS
There were no material changes in our risk factors previously disclosed in Part I, Item 1A “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2014. You should carefully consider the risks and uncertainties described therein.
ITEM 6.
EXHIBITS
Exhibits to this Report are as follows:
Incorporated by Reference
ExhibitNumber
Exhibit Description
Filed Herewith
Form
Period Ending
Exhibit /Appendix Number
Filing Date
31.1
Section 302 Certification – CEO
X
31.2
Section 302 Certification – CFO
32.1
Section 906 Certification – CEO
32.2
Section 906 Certification – CFO
101.INS
XBRL Instance Document.
101.SCH
XBRL Taxonomy Extension Schema Document.
101.CAL
XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF
XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB
XBRL Taxonomy Extension Label Linkbase Document.
101.PRE
XBRL Taxonomy Extension Presentation Linkbase Document.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Gentherm Incorporated
/s/ DANIEL R. COKER
Daniel R. Coker
Chief Executive Officer
(Duly Authorized Officer)
Date: May 1, 2015
/s/ BARRY G. STEELE
Barry G. Steele
Chief Financial Officer
(Principal Financial Officer and Principal Accounting Officer)